SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000902664-16-005788
Filing Date
2016-02-16
Accepted
2016-02-16 11:30:01
Documents
1

Document Format Files

Seq Description Document Type Size
1 CYMABAY THERAPEUTICS, INC. p16-0590sc13ga.htm SC 13G/A 53293
  Complete submission text file 0000902664-16-005788.txt   54979
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Subject) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87950 | Film No.: 161424888
SIC: 2834 Pharmaceutical Preparations

Mailing Address 452 FIFTH AVENUE, 25TH FLOOR NEW YORK NY 10018
Business Address 452 FIFTH AVENUE, 25TH FLOOR NEW YORK NY 10018 212-295-6200
Lombard Odier Asset Management (USA) Corp (Filed by) CIK: 0001491719 (see all company filings)

IRS No.: 061603711 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A